Anti-Human CXCR4 Therapeutic Antibody (CF172)
This novel anti-CXCR4 mAb, CF172, with specific reactivity against human CXCR4, is proved to prevent peritoneal metastasis and lymph node metastasis of rhabdomyosarcoma in animal models. It suggests that CF172 is a potential anti-metastasis therapeutic antibody for rhabdomyosarcoma treatment.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-150MZ |
| Pricing | Inquiry |
| Type | Human antibody |
| Applications | Flow Cytometry |
| Host | Human |
| Target | CXCR4 (Chemokine C-X-C motif receptor 4) |